Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?

References

• Amant F, Lefrère H, Borges VF, et al. The definition of pregnancy-associated breast cancer is outdated and should no longer be used. Lancet Oncol. 2021;22(6):753–754. doi: 10.1016/S1470-2045(21)00183-2
   PubMed Web of Science ®Google Scholar
• Cottreau CM, Dashevsky I, Andrade SE, et al. Pregnancy-associated cancer: a U.S. Population-based study. J Womens Health. 2019;28(2):250–257. doi: 10.1089/jwh.2018.6962
   PubMed Web of Science ®Google Scholar
• Smith LH, Dalrymple JL, Leiserowitz GS, et al. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184(7):1504–1513. doi: 10.1067/mob.2001.114867
   PubMed Web of Science ®Google Scholar
• Dalmartello M, Negri E, La Vecchia C, et al. Frequency of pregnancy-associated cancer: a systematic review of population-based studies. Cancers (Basel). 2020;12(6):1356. doi: 10.3390/cancers12061356
   PubMed Web of Science ®Google Scholar
• Schwab R, Anic K, Hasenburg A. Cancer and pregnancy: a comprehensive review. Cancers (Basel). 2021;13(12):3048. doi: 10.3390/cancers13123048
   PubMed Web of Science ®Google Scholar
• Sorouri K, Loren AW, Amant F, et al. Patient-centered care in the management of cancer during pregnancy. Am Soc Clin Oncol Educ Book. 2023;(43):e100037. doi: 10.1200/EDBK_100037
   PubMedGoogle Scholar
• Silverstein J, Post AL, Chien AJ, et al. Multidisciplinary management of cancer during pregnancy. JCO Oncol Pract. 2020;16(9):545–557. doi: 10.1200/OP.20.00077
   PubMedGoogle Scholar
• Peccatori FA, Azim HA, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi160–vi170. doi: 10.1093/annonc/mdt199
   PubMed Web of Science ®Google Scholar
• Linkeviciute A, Canario R, Peccatori FA, et al. Guidelines for cancer treatment during pregnancy: Ethics-related content Evolution and implications for Clinicians. Cancers (Basel). 2022;14(17):4325. doi: 10.3390/cancers14174325
   PubMed Web of Science ®Google Scholar
• Leung V, Bryant C, Stafford L. Psychological aspects of gestational cancer: a systematic review. Psychooncology. 2020;29(11):1734–1745. doi: 10.1002/pon.5502
   PubMed Web of Science ®Google Scholar
• Harris J, Ream E, Armes J, et al. What do we know about the psychosocial issues associated with cancer during pregnancy? A scoping review and gap analysis. BMJ Open. 2023;13(3):e063283. doi: 10.1136/bmjopen-2022-063283
   PubMed Web of Science ®Google Scholar
• Amant F, Von Minckwitz G, Han SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013;31(20):2532–2539. doi: 10.1200/JCO.2012.45.6335
   PubMed Web of Science ®Google Scholar
• Amant F, Nekljudova V, Maggen C, et al. Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls. Eur J Cancer. 2022;170:54–63. doi: 10.1016/j.ejca.2022.04.014
   PubMed Web of Science ®Google Scholar
• Johansson ALV, Fredriksson I, Mellemkjaer L, et al. Cancer survival in women diagnosed with pregnancy-associated cancer: an overview using nationwide registry data in Sweden 1970–2018. Eur J Cancer. 2021;155:106–115. doi: 10.1016/j.ejca.2021.07.008
   PubMed Web of Science ®Google Scholar
• Bakhuis CFJ, Suelmann BBM, Van Dooijeweert C, et al. Receptor status of breast cancer diagnosed during pregnancy: a literature review. Crit Rev Oncol Hematol. 2021;168:103494. doi: 10.1016/j.critrevonc.2021.103494
   PubMed Web of Science ®Google Scholar
• Ulery M, Carter L, McFarlin BL, et al. Pregnancy-associated breast cancer: significance of early detection. J Midwifery Womens Health. 2009;54(5):357–363. doi: 10.1016/j.jmwh.2008.12.007
   PubMed Web of Science ®Google Scholar
• Vashi R, Hooley R, Butler R, et al. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer. Am J Roentgenol. 2013;200(2):321–328. doi: 10.2214/AJR.12.9814
   PubMed Web of Science ®Google Scholar
• Nguyen T, Bhosale PR, Cassia L, et al. Malignancy in pregnancy: Multimodality imaging and treatment. Cancer. 2023;129(10):1479–1491. doi: 10.1002/cncr.34688
   PubMed Web of Science ®Google Scholar
• Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015;1(8):1145. doi: 10.1001/jamaoncol.2015.2413
   PubMed Web of Science ®Google Scholar
• Nissan N, Bauer E, Moss Massasa EE, et al. Breast MRI during pregnancy and lactation: clinical challenges and technical advances. Insights Imaging. 2022;13(1):71. doi: 10.1186/s13244-022-01214-7
   PubMed Web of Science ®Google Scholar
• Peccatori FA, Codacci-Pisanelli G, Del Grande M, et al. Whole body MRI for systemic staging of breast cancer in pregnant women. Breast. 2017;35:177–181. doi: 10.1016/j.breast.2017.07.014
   PubMed Web of Science ®Google Scholar
• Paluch-Shimon S, Cardoso F, Partridge AH, et al. ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5). Ann Oncol. 2022;33(11):1097–1118. doi: 10.1016/j.annonc.2022.07.007
   PubMed Web of Science ®Google Scholar
• Denduluri N, Chavez-MacGregor M, Telli ML, et al. Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2018;36(23):2433–2443. doi: 10.1200/JCO.2018.78.8604
   PubMed Web of Science ®Google Scholar
• Liberale V, Tripodi E, Ottino L, et al. Surgery on breast cancer in pregnancy. Transl Cancer Res. 2019;8(S5):S493–S502. doi: 10.21037/tcr.2019.07.16
   PubMedGoogle Scholar
• Webb MP, Helander EM, Meyn AR, et al. Preoperative assessment of the pregnant patient undergoing nonobstetric surgery. Anesthesiol Clin. 2018;36(4):627–637. doi: 10.1016/j.anclin.2018.07.010
   PubMedGoogle Scholar
• On behalf of the International Network on Cancer, Infertility and Pregnancy, Han SN, Amant F, et al. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy. Breast Cancer Res Treat. 2018;168(2):551–557.
   PubMed Web of Science ®Google Scholar
• Wolters V, Heimovaara J, Maggen C, et al. Management of pregnancy in women with cancer. Int J Gynecol Cancer. 2021;31(3):314–322. doi: 10.1136/ijgc-2020-001776
   PubMed Web of Science ®Google Scholar
• Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6(5):328–333. doi: 10.1016/S1470-2045(05)70169-8
   PubMed Web of Science ®Google Scholar
• Toesca A, Gentilini O, Peccatori F, et al. Locoregional treatment of breast cancer during pregnancy. Gynecol Surg. 2014;11(4):279–284. doi: 10.1007/s10397-014-0860-6
   PubMedGoogle Scholar
• Lohsiriwat V, Peccatori FA, Martella S, et al. Immediate breast reconstruction with expander in pregnant breast cancer patients. Breast. 2013;22(5):657–660. doi: 10.1016/j.breast.2013.06.005
   PubMed Web of Science ®Google Scholar
• Caragacianu DL, Mayer EL, Chun YS, et al. Immediate breast reconstruction following mastectomy in pregnant women with breast cancer: breast reconstruction in pregnancy. J Surg Oncol. 2016;114(2):140–143. doi: 10.1002/jso.24308
   PubMed Web of Science ®Google Scholar
• Poggio F, Tagliamento M, Pirrone C, et al. Update on the management of breast cancer during pregnancy. Cancers (Basel). 2020;12(12):3616. doi: 10.3390/cancers12123616
   PubMed Web of Science ®Google Scholar
• Van Calsteren K, Verbesselt R, Ottevanger N, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand. 2010;89(10):1338–1345. doi: 10.3109/00016349.2010.512070
   PubMed Web of Science ®Google Scholar
• Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283–291. doi: 10.1016/S1470-2045(04)01466-4
   PubMed Web of Science ®Google Scholar
• Leslie KK, Koil C, Rayburn WF. Chemotherapeutic drugs in pregnancy. Obstet Gynecol Clin North Am. 2005;32(4):627–640. doi: 10.1016/j.ogc.2005.08.009
   PubMed Web of Science ®Google Scholar
• Fedro AP, Matteo L, Giovanna S, et al. Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences. Cancer Biol Med. 2018;15(1):6. doi: 10.20892/j.issn.2095-3941.2017.0146
   PubMed Web of Science ®Google Scholar
• Beadle BM, Woodward WA, Middleton LP, et al. The impact of pregnancy on breast cancer outcomes in women ≤35 years. Cancer. 2009;115(6):1174–1184. doi: 10.1002/cncr.24165
   PubMed Web of Science ®Google Scholar
• Van Calsteren K, Verbesselt R, Beijnen J, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol. 2010;119(3):594–600. doi: 10.1016/j.ygyno.2010.08.019
   PubMed Web of Science ®Google Scholar
• Bar-Joseph H, Peccatori FA, Goshen-Lago T, et al. Cancer during pregnancy: the role of vascular toxicity in chemotherapy-induced placental toxicity. Cancers (Basel). 2020;12(5):1277. doi: 10.3390/cancers12051277
   PubMed Web of Science ®Google Scholar
• Braybrooke J, Bradley R, Gray R, et al. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials. Lancet. 2023;401(10384):1277–1292. doi: 10.1016/S0140-6736(23)00285-4
   PubMed Web of Science ®Google Scholar
• Tesarova P, Pavlista D, Parizek A. Is it possible to personalize the diagnosis and treatment of breast cancer during pregnancy? J Pers Med. 2020;11(1):18. doi: 10.3390/jpm11010018
   PubMed Web of Science ®Google Scholar
• Hahn KME, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107(6):1219–1226. doi: 10.1002/cncr.22081
   PubMed Web of Science ®Google Scholar
• Del Mastro L, Poggio F, Blondeaux E, et al. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial. Lancet Oncol. 2022;23(12):1571–1582. doi: 10.1016/S1470-2045(22)00632-5
   PubMed Web of Science ®Google Scholar
• Peccatori FA, Azim HA, Scarfone G, et al. Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat. 2009;115(3):591–594. doi: 10.1007/s10549-008-0159-2
   PubMed Web of Science ®Google Scholar
• Benoit L, Mir O, Vialard F, et al. Cancer during pregnancy: a review of preclinical and clinical Transplacental transfer of anticancer agents. Cancers (Basel). 2021;13(6):1238. doi: 10.3390/cancers13061238
   PubMed Web of Science ®Google Scholar
• Ferrigno Guajardo AS, Vaca-Cartagena BF, Mayer EL, et al. Taxanes for the treatment of breast cancer during pregnancy: an international cohort study. J Natl Cancer Inst. 2023Dec 7; djad219. doi: 10.1093/jnci/djad219. Online ahead of print. PMID: 38059798.
   PubMedGoogle Scholar
• Sella T, Exman P, Ren S, et al. Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis. Breast Cancer Res Treat. 2022;194(3):597–606. doi: 10.1007/s10549-022-06621-4
   PubMed Web of Science ®Google Scholar
• Poggio F, Bruzzone M, Ceppi M, et al. Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol. 2018;29(7):1497–1508. doi: 10.1093/annonc/mdy127
   PubMed Web of Science ®Google Scholar
• Poggio F, Tagliamento M, Ceppi M, et al. Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate. Ann Oncol. 2022;33(3):347–349. doi: 10.1016/j.annonc.2021.11.016
   PubMed Web of Science ®Google Scholar
• De Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337–346. doi: 10.1016/S1470-2045(18)30059-7
   PubMed Web of Science ®Google Scholar
• Mir O, Berveiller P, Ropert S, et al. Use of platinum derivatives during pregnancy. Cancer. 2008;113(11):3069–3074. doi: 10.1002/cncr.23935
   PubMed Web of Science ®Google Scholar
• Lambertini M, Ceppi M, Cognetti F, et al. Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: a pooled analysis of the MIG1 and GIM2 phase III studies. Eur J Cancer. 2017;71:34–42. doi: 10.1016/j.ejca.2016.10.030
   PubMed Web of Science ®Google Scholar
• Cardonick E, Gilmandyar D, Somer RA. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol. 2012;120(6):1267–1272. doi: 10.1097/AOG.0b013e31826c32d9
   PubMed Web of Science ®Google Scholar
• Buonomo B, Brunello A, Noli S, et al. Tamoxifen exposure during pregnancy: a systematic review and three more cases. Breast Care. 2020;15(2):148–156. doi: 10.1159/000501473
   PubMed Web of Science ®Google Scholar
• Lambertini M, Peccatori FA, Demeestere I, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO clinical practice guidelines†. Ann Oncol. 2020;31(12):1664–1678. doi: 10.1016/j.annonc.2020.09.006
   PubMed Web of Science ®Google Scholar
• Peccatori FA, Codacci-Pisanelli G, Mellgren G, et al. First-in-human pharmacokinetics of tamoxifen and its metabolites in the milk of a lactating mother: a case study. ESMO Open. 2020;5(5):e000859. doi: 10.1136/esmoopen-2020-000859
   PubMed Web of Science ®Google Scholar
• Tiboni GM, Ponzano A. Fetal safety profile of aromatase inhibitors: Animal data. Reprod Toxicol. 2016;66:84–92. doi: 10.1016/j.reprotox.2016.09.016
   PubMed Web of Science ®Google Scholar
• Poorvu PD, Gelber SI, Zheng Y, et al. Pregnancy after breast cancer: results from a prospective cohort of young women with breast cancer. Cancer. 2021;127(7):1021–1028. doi: 10.1002/cncr.33342
   PubMed Web of Science ®Google Scholar
• Lambertini M, Massarotti C, Havas J, et al. Contraceptive use in premenopausal women with early breast cancer. JAMA Netw Open. 2022;5(9):e2233137. doi: 10.1001/jamanetworkopen.2022.33137
   PubMed Web of Science ®Google Scholar
• Ye F, Dewanjee S, Li Y, et al. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer. 2023;22(1):105. doi: 10.1186/s12943-023-01805-y
   PubMed Web of Science ®Google Scholar
• Lambertini M, Peccatori FA, Azim HA. Targeted agents for cancer treatment during pregnancy. Cancer Treat Rev. 2015;41(4):301–309. doi: 10.1016/j.ctrv.2015.03.001
   PubMed Web of Science ®Google Scholar
• Xia L-Y, Hu Q-L, Zhou Q. Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis. BMC Womens Health. 2021;21(1):169. doi: 10.1186/s12905-021-01301-9
   PubMed Web of Science ®Google Scholar
• Goodyer PR, Cybulsky A, Goodyer C. Expression of the epidermal growth factor receptor in fetal kidney. Pediatr Nephrol. 1993;7(5):612–615. doi: 10.1007/BF00852567
   PubMed Web of Science ®Google Scholar
• Andrikopoulou A, Apostolidou K, Chatzinikolaou S, et al. Trastuzumab administration during pregnancy: an update. BMC Cancer. 2021;21(1):463. doi: 10.1186/s12885-021-08162-3
   PubMed Web of Science ®Google Scholar
• Lambertini M, Martel S, Campbell C, et al. Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials: pregnancies in women with HER2+ breast cancer. Cancer. 2019;125(2):307–316. doi: 10.1002/cncr.31784
   PubMed Web of Science ®Google Scholar
• An Observational study of pregnancy and pregnancy outcomes in women with breast cancer treated with herceptin, Perjeta in combination with herceptin, or kadcyla during pregnancy or within 7 months prior to conception [internet]. ClinicalTrials.gov Identifier: NCT00833963.
   Google Scholar
• Schmid P, Cortes J, Pusztai L, et al. Pembrolizumab for Early Triple-Negative Breast Cancer. N Engl J Med. 2020;382(9):810–821. doi: 10.1056/NEJMoa1910549
   PubMed Web of Science ®Google Scholar
• Schmid P, Cortés J, Dent RA, et al. LBA18 Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: updated EFS results from the phase III KEYNOTE-522 study. Ann Oncol. 2023;34:S1257. doi: 10.1016/j.annonc.2023.10.008
   Google Scholar
• Zhang Y-H, Tian M, Tang M-X, et al. Recent insight into the role of the PD-1/PD-L1 pathway in feto-maternal tolerance and pregnancy. Am J Reprod Immunol. 2015;74(3):201–208. doi: 10.1111/aji.12365
   PubMed Web of Science ®Google Scholar
• Habicht A, Dada S, Jurewicz M, et al. A link between PDL1 and T Regulatory cells in Fetomaternal tolerance. J Immunol. 2007;179(8):5211–5219. doi: 10.4049/jimmunol.179.8.5211
   PubMed Web of Science ®Google Scholar
• Guleria I, Khosroshahi A, Ansari MJ, et al. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med. 2005;202(2):231–237. doi: 10.1084/jem.20050019
   PubMed Web of Science ®Google Scholar
• Garutti M, Lambertini M, Puglisi F. Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review. ESMO Open. 2021;6(5):100276. doi: 10.1016/j.esmoop.2021.100276
   PubMed Web of Science ®Google Scholar
• Borgers JSW, Heimovaara JH, Cardonick E, et al. Immunotherapy for cancer treatment during pregnancy. Lancet Oncol. 2021;22(12):e550–e561. doi: 10.1016/S1470-2045(21)00525-8
   PubMed Web of Science ®Google Scholar
• Baarslag MA, Heimovaara JH, Borgers JSW, et al. Severe immune-related enteritis after in utero exposure to Pembrolizumab. N Engl J Med. 2023;389(19):1790–1796. doi: 10.1056/NEJMoa2308135
   PubMedGoogle Scholar
• Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid: Offic J Am Thyroid Association. 2002;12(1):63–68. doi: 10.1089/105072502753451986
   PubMed Web of Science ®Google Scholar
• Herrstedt J, Roila F, Warr D, et al. 2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high emetic risk chemotherapy. Support Care Cancer. 2017;25(1):277–288. doi: 10.1007/s00520-016-3313-0
   PubMed Web of Science ®Google Scholar
• Pasternak B, Svanström H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013;368(9):814–823. doi: 10.1056/NEJMoa1211035
   PubMed Web of Science ®Google Scholar
• ACOG practice bulletin no. 189: nausea and vomiting of pregnancy. Obstet Gynecol. 2018;131(1):e15–e30. doi: 10.1097/AOG.0000000000002456
   PubMedGoogle Scholar
• Picot C, Berard A, Grenet G, et al. Risk of malformation after ondansetron in pregnancy: an updated systematic review and meta‐analysis. Birth Defects Res. 2020;112(13):996–1013. doi: 10.1002/bdr2.1705
   PubMedGoogle Scholar
• Crowther CA, Doyle LW, Haslam RR, et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357(12):1179–1189. doi: 10.1056/NEJMoa071152
   PubMed Web of Science ®Google Scholar
• Alexander N, Rosenlöcher F, Stalder T, et al. Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J Clin Endocrinol Metab. 2012;97(10):3538–3544. doi: 10.1210/jc.2012-1970
   PubMed Web of Science ®Google Scholar
• Wallensteen L, Zimmermann M, Thomsen Sandberg M, et al. Sex-dimorphic effects of prenatal treatment with dexamethasone. J Clin Endocrinol Metab. 2016;101(10):3838–3846. doi: 10.1210/jc.2016-1543
   PubMed Web of Science ®Google Scholar
• Zagouri F, Dedes N, Papatheodoridi A, et al. Supportive medication in cancer during pregnancy. Bmc Pregnancy Childbirth. 2020;20(1):747. doi: 10.1186/s12884-020-03432-7
   PubMed Web of Science ®Google Scholar
• Garbis H, Elefant E, Diavcitrin O, et al. Pregnancy outcome after exposure to ranitidine and other H2-blockersA collaborative study of the European Network of Teratology Information Services. Reprod Toxicol. 2005;19(4):453–458. doi: 10.1016/j.reprotox.2004.09.002
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Rosa C, Christensen RD. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery. Am J Obstet Gynecol. 1996;174(4):1306–1311. doi: 10.1016/S0002-9378(96)70676-2
   PubMed Web of Science ®Google Scholar
• Berends C, Maggen C, Lok CAR, et al. Maternal and neonatal outcome after the use of G-CSF for cancer treatment during pregnancy. Cancers (Basel). 2021;13(6):1214. doi: 10.3390/cancers13061214
   PubMed Web of Science ®Google Scholar
• Lu D, Ludvigsson JF, Smedby KE, et al. Maternal cancer during pregnancy and risks of stillbirth and infant mortality. J Clin Oncol. 2017;35(14):1522–1529. doi: 10.1200/JCO.2016.69.9439
   PubMed Web of Science ®Google Scholar
• Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric outcome after Maternal cancer diagnosed during pregnancy. N Engl J Med. 2015;373(19):1824–1834. doi: 10.1056/NEJMoa1508913
   PubMed Web of Science ®Google Scholar
• Van Assche IA, In ’t Veld EH, Van Calsteren K, et al. Cognitive and behavioral development of 9-year-old children after maternal cancer during pregnancy: a prospective multicenter cohort study. J Clin Oncol. 2023;41(8):1527–1532. doi: 10.1200/JCO.22.02005
   PubMed Web of Science ®Google Scholar
• Peccatori FA, Migliavacca Zucchetti B, Buonomo B, et al. Lactation during and after breast cancer. Adv Exp Med Biol. 2020;1252:159–163.
   PubMed Web of Science ®Google Scholar
• Lambertini M, Kamal NS, Peccatori FA, et al. Exploring the safety of chemotherapy for treating breast cancer during pregnancy. Expert Opin Drug Saf. 2015;14(9):1395–1408. doi: 10.1517/14740338.2015.1061500
   PubMed Web of Science ®Google Scholar
• Cardonick E, Dougherty R, Grana G, et al. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010;16(1):76–82. doi: 10.1097/PPO.0b013e3181ce46f9
   PubMed Web of Science ®Google Scholar
• Alpuim Costa D, Nobre JG, De Almeida SB, et al. Cancer during pregnancy: how to handle the bioethical dilemmas?—A scoping review with Paradigmatic cases-based analysis. Front Oncol. 2020;10:598508. doi: 10.3389/fonc.2020.598508
   PubMed Web of Science ®Google Scholar